Copaxone effectiveness? (or lack of?)
Posted: Wed Jan 26, 2005 3:56 am
I've been reading mixed reports on the web about copaxone and it's effectiveness.
http://www.msworld.org/Resource_Center/ ... edcop.html
^^^^
Seems the most promising data I can find, which is consistent to what I read. The longer one takes copaxone, the better it will work. This seems to be ideal in my situation as I'm young and was picked up in MS's early stages. I dont feel I need to go on an "Agressive" interferon as it ruins my quality of life.
So basically two studies say it's does nothing, one even says it makes it worse. This is quite concerning for me because I can't really handle interferon.
I'm having a hard time what to believe. I will take this stuff IF IT WORKS, but from what I read, it's very hit and miss, and the studies shown could have easily been ones where the patients did better by chance or had less disease progression than the other group, none specify.
Can anyone guide me on this, or direct me to a GOOD study? PM's will be fine if you dont wanna bag copaxone in public. I'm not bagging them, im just questioning it's "Efficacy". From what I gather, it's basically useless. I hear from some people it's great though.
I'm a bit lost. At first I thought copaxone was the shiznit, but now I'm starting to wonder. It seems good in theory how it works, but I get very mixed reports.
My "Research" is below, if anyone could perhaps verify, or exapand on it, or point out anything I've obviously missed that'd be good. Sorry for my long post, but for me, deciding between this, or no med, may be one of the most important decisions of my life
PS: I will also endevour to be taking LDN, havent started on it yet, but results looks very promising from the anecdotal evidence. I intend on combining the two therapies.
-------------------------------------------------------------------------------------
http://www.themcfox.com/multiple-sclero ... veness.htm shows that copaxone was 7% more effective (relapse rate wise) than a placebo. Not very promising.
How effective is Copaxone ®?
% of patients relapse free at 2 years
Placebo 27%
Copaxone 34%
Number of patients progression free† completing 2 years of Copaxone ®
% of patients progression free at 2 years
Placebo 75%
Copaxone ® 78%
Mean relapse rate
Mean relapse rate over 2 years
Placebo 1.68
Copaxone ® 1.19
Average time to first relapse
Placebo 198 days
Copaxone 287 days
-------------------------------------------------------------------------------------
http://www.msakc.org/medical/treatments/Copax1.htm states 0.6 on copaxone relapses vs 2.4 for placebo, that result is much varied from the other one
Also from that site-
"To test the therapeutic impact and tolerability of Copaxone, a second study was conducted at 11 different medical centers with 251 relapsing-remitting MS patients. In this study patients were given Copaxone or placebo for 24 months and the primary measure was the reduction of relapses. At the end of the 24-month trial, patients on Copaxone had a lower average number of relapses (1.19 for Copaxone compared to 1.68 for placebo). This difference equated to a 29% reduction in relapses between Copaxone and placebo-treated patients. Further analysis of the study showed that 24% of the Copaxone treated patients were relapse-free at the end of the study versus 27% of the placebo-treated patients. Also, the average time before the first relapse was more than 30% later with the Copaxone group than with the placebo group"
Doesnt that basically say that taking nothing was 3% more effective than taking copaxone? I dont understand. Perhaps someone can clarify, or they have their numbers wrong, or I should just dismiss this site completely. (URL above)
"Measuring on the EDSS (Expanded Disability Status Scale), most patients in the study did not experience confirmed sustained progression of disability (98 out of 125 or 78% of Copaxone patients and 95 out of 126, or 75% of placebo patients)."
-------------------------------------------------------------------------------------
http://www.mult-sclerosis.org/Copaxone.html
6 of the placebo group (26%) and 14 of the Cop-1 group (56%) had no relapses. There were 62 relapses in the placebo group (average 2.7 per person) and 16 in the Cop 1 group(average 0.6)
Final 2-year relapse rate was 1.19 for patients receiving Cop-1 and 1.68 or those receiving placebo, a 29% reduction in favor of cop-1. Disability levels (EDSS) were also better in the Cop-1 group
ed: That's slightly more promising?
-------------------------------------------------------------------------------------
http://www.msworld.org/Resource_Center/ ... edcop.html
During the six-year study, the mean relapse rate was 2.23 (95 percent Confidence Interval equals 1.78-2.68). This equated to an overall mean annual relapse rate of 0.42 (95 percent Confidence Interval equals 0.34-0.51; P equals 0.0001) per year for the 101 patients receiving Copaxone for six years. The relapse rate has continued to fall and during the last two years, patients are, on average, at risk of having a relapse every four-plus years.
-------------------------------------------------------------------------------------
http://www.msworld.org/Resource_Center/ ... edcop.html
^^^^
Seems the most promising data I can find, which is consistent to what I read. The longer one takes copaxone, the better it will work. This seems to be ideal in my situation as I'm young and was picked up in MS's early stages. I dont feel I need to go on an "Agressive" interferon as it ruins my quality of life.
So basically two studies say it's does nothing, one even says it makes it worse. This is quite concerning for me because I can't really handle interferon.
I'm having a hard time what to believe. I will take this stuff IF IT WORKS, but from what I read, it's very hit and miss, and the studies shown could have easily been ones where the patients did better by chance or had less disease progression than the other group, none specify.
Can anyone guide me on this, or direct me to a GOOD study? PM's will be fine if you dont wanna bag copaxone in public. I'm not bagging them, im just questioning it's "Efficacy". From what I gather, it's basically useless. I hear from some people it's great though.
I'm a bit lost. At first I thought copaxone was the shiznit, but now I'm starting to wonder. It seems good in theory how it works, but I get very mixed reports.
My "Research" is below, if anyone could perhaps verify, or exapand on it, or point out anything I've obviously missed that'd be good. Sorry for my long post, but for me, deciding between this, or no med, may be one of the most important decisions of my life
PS: I will also endevour to be taking LDN, havent started on it yet, but results looks very promising from the anecdotal evidence. I intend on combining the two therapies.
-------------------------------------------------------------------------------------
http://www.themcfox.com/multiple-sclero ... veness.htm shows that copaxone was 7% more effective (relapse rate wise) than a placebo. Not very promising.
How effective is Copaxone ®?
% of patients relapse free at 2 years
Placebo 27%
Copaxone 34%
Number of patients progression free† completing 2 years of Copaxone ®
% of patients progression free at 2 years
Placebo 75%
Copaxone ® 78%
Mean relapse rate
Mean relapse rate over 2 years
Placebo 1.68
Copaxone ® 1.19
Average time to first relapse
Placebo 198 days
Copaxone 287 days
-------------------------------------------------------------------------------------
http://www.msakc.org/medical/treatments/Copax1.htm states 0.6 on copaxone relapses vs 2.4 for placebo, that result is much varied from the other one
Also from that site-
"To test the therapeutic impact and tolerability of Copaxone, a second study was conducted at 11 different medical centers with 251 relapsing-remitting MS patients. In this study patients were given Copaxone or placebo for 24 months and the primary measure was the reduction of relapses. At the end of the 24-month trial, patients on Copaxone had a lower average number of relapses (1.19 for Copaxone compared to 1.68 for placebo). This difference equated to a 29% reduction in relapses between Copaxone and placebo-treated patients. Further analysis of the study showed that 24% of the Copaxone treated patients were relapse-free at the end of the study versus 27% of the placebo-treated patients. Also, the average time before the first relapse was more than 30% later with the Copaxone group than with the placebo group"
Doesnt that basically say that taking nothing was 3% more effective than taking copaxone? I dont understand. Perhaps someone can clarify, or they have their numbers wrong, or I should just dismiss this site completely. (URL above)
"Measuring on the EDSS (Expanded Disability Status Scale), most patients in the study did not experience confirmed sustained progression of disability (98 out of 125 or 78% of Copaxone patients and 95 out of 126, or 75% of placebo patients)."
-------------------------------------------------------------------------------------
http://www.mult-sclerosis.org/Copaxone.html
6 of the placebo group (26%) and 14 of the Cop-1 group (56%) had no relapses. There were 62 relapses in the placebo group (average 2.7 per person) and 16 in the Cop 1 group(average 0.6)
Final 2-year relapse rate was 1.19 for patients receiving Cop-1 and 1.68 or those receiving placebo, a 29% reduction in favor of cop-1. Disability levels (EDSS) were also better in the Cop-1 group
ed: That's slightly more promising?
-------------------------------------------------------------------------------------
http://www.msworld.org/Resource_Center/ ... edcop.html
During the six-year study, the mean relapse rate was 2.23 (95 percent Confidence Interval equals 1.78-2.68). This equated to an overall mean annual relapse rate of 0.42 (95 percent Confidence Interval equals 0.34-0.51; P equals 0.0001) per year for the 101 patients receiving Copaxone for six years. The relapse rate has continued to fall and during the last two years, patients are, on average, at risk of having a relapse every four-plus years.
-------------------------------------------------------------------------------------